The female hormone estrogen may hold important clues for scientists working on new therapies for colon cancer, a study by Dana-Farber Cancer Institute researchers suggests.
VIB and AlgoNomics have joined forces to develop a technology that verifies whether certain proteins induce an immune response in humans. The collaboration between VIB and AlgoNomics has yielded a biological test that supplements the current computer simulations. The additional data enable a more precise determination of the immune response.
A new study will provide further understanding about the effects of omega-3 fatty acids on the brain function of children with Attention Deficit Hyperactivity Disorder (ADHD).
Teenagers who take a daily multivitamin supplement have a healthier diet and lifestyle than those who don’t take vitamins, reports a study in the December Journal of the American Dietetic Association.
A London School of Hygiene and Tropical Medicine team revealed that women who are very underweight before they become pregnant are 72% more likely to miscarry in the first three months of pregnancy.
The December 2006 issue of the Journal of the American Dietetic Association contains articles and research studies you may find of interest. Below is a summary of some of this month’s articles.
People with auto-immune conditions like MS, arthritis and lupus can benefit from low impact aerobic exercise — including walking and cycling — that increases in intensity, duration and frequency. A review of studies between 1987 and 2006 shows that 12-week programmes that involved exercising for 30 to 60 minutes, three times a week, yielded the most effective results.
Families from low income households across the England will benefit from a new scheme from Monday 27 November, giving free milk and fresh fruit and vegetables to children and mums-to-be, as Healthy Start – first piloted in Devon and Cornwall – extends to the rest of the country.
Bristol-Myers Squibb Company (NYSE: BMY) today announced that two-year data from three Phase III pivotal trials demonstrate the long-term efficacy of ORENCIA? (abatacept) in adult patients with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate and TNF antagonists. The data also demonstrate that ORENCIA provided clinically meaningful improvements in multiple aspects of health-related quality of life and physical function, sustained improvements in pain and had a consistent safety and tolerability profile through two years of treatment. These data will be presented at the upcoming 2006 American College of Rheumatology (ACR) Annual Scientific Meeting.
Researchers at the Cancer Treatment Centers of America found that antioxidant therapies such as green tea extract, melatonin, high-potency multivitamins, vitamin C and vitamin E do not interfere with radiation treatment.